Exane Derivatives’s Bristol-Myers Squibb BMY Stock Holding History

Exane Derivatives’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	$1.32M	Buy	17,094 +6,261	+58%	+$482K	0.76%	30
2022 Q1	$791K	Sell	10,833 -11,351	-51%	-$829K	0.22%	122
2021 Q4	$1.38M	Buy	22,184 +4,175	+23%	+$260K	0.33%	60
2021 Q3	$1.07M	Buy	18,009 +470	+3%	+$27.8K	0.26%	78
2021 Q2	$1.18M	Sell	17,539 -1,165	-6%	-$78.6K	0.27%	82
2021 Q1	$1.18M	Sell	18,704 -307	-2%	-$19.4K	0.34%	63
2020 Q4	$1.18M	Sell	19,011 -17,572	-48%	-$1.09M	0.35%	59
2020 Q3	$2.21M	Buy	36,583 +18,001	+97%	+$1.09M	0.64%	31
2020 Q2	$1.09M	Sell	18,582 -2,968	-14%	-$175K	0.29%	79
2020 Q1	$1.2M	Sell	21,550 -826	-4%	-$46K	0.34%	67
2019 Q4	$1.49M	Buy	22,376 +6,485	+41%	+$432K	0.28%	88
2019 Q3	$806K	Buy	15,891 +10,200	+179%	+$517K	0.14%	113
2019 Q2	$258K	Sell	5,691 -8,429	-60%	-$382K	0.05%	221
2019 Q1	$673K	Sell	14,120 -13,061	-48%	-$623K	0.13%	130
2018 Q4	$1.41M	Buy	27,181 +22,454	+475%	+$1.17M	0.25%	81
2018 Q3	$293K	Sell	4,727 -6,517	-58%	-$404K	0.06%	196
2018 Q2	$626K	Buy	11,244 +6,320	+128%	+$352K	0.1%	148
2018 Q1	$309K	Buy	4,924 +266	+6%	+$16.7K	0.06%	184
2017 Q4	$286K	Buy	4,658 +1,055	+29%	+$64.7K	0.05%	190
2017 Q3	$230K	Sell	3,603 -2,013	-36%	-$128K	0.04%	170
2017 Q2	$313K	Sell	5,616 -1,568	-22%	-$87.4K	0.07%	156
2017 Q1	$391K	Buy	7,184 +5,414	+306%	+$294K	0.09%	137
2016 Q4	$103K	Sell	1,770 -14,361	-89%	-$839K	0.02%	224
2016 Q3	$870K	Buy	16,131 +13,491	+511%	+$727K	0.13%	93
2016 Q2	$194K	Sell	2,640 -2,505	-49%	-$184K	0.03%	202
2016 Q1	$329K	Buy	5,145 +836	+19%	+$53.4K	0.04%	143
2015 Q4	$296K	Buy	4,309 +1,831	+74%	+$126K	0.04%	125
2015 Q3	$147K	Buy	2,478 +1,388	+127%	+$82.2K	0.02%	177
2015 Q2	$72.5K	Hold	1,090	–	–	0.01%	236
2015 Q1	$70.3K	Sell	1,090 -1,606	-60%	-$104K	0.01%	255
2014 Q4	$159K	Buy	+2,696	New	+$159K	0.02%	215